John Edward Morley
Keine laufenden Positionen mehr
Karriereverlauf von John Edward Morley
Ehemalige bekannte Positionen von John Edward Morley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
St. Louis University | Corporate Officer/Principal | - | - |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | Corporate Officer/Principal | - | - |
University of California, Berkeley | Corporate Officer/Principal | - | - |
VA Medical Center (District of Columbia) | Corporate Officer/Principal | - | - |
Edunn Biotechnology, Inc.
Edunn Biotechnology, Inc. Pharmaceuticals: GenericHealth Technology Edunn Biotechnology, Inc. develops drugs to treat central nervous system diseases. The firm engages in developing oligonucleotide drugs to treat central nervous system diseases. The company was founded in September 2005 and is headquartered in St. Louis, MO. | Direktor/Vorstandsmitglied | 30.09.2009 | 09.06.2010 |
Gründer | 30.09.2009 | - | |
Corporate Officer/Principal | 01.09.2005 | - |
Ausbildung von John Edward Morley
University of the Witwatersrand | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Südafrika | 2 |
Operativ
Corporate Officer/Principal | 5 |
Director/Board Member | 1 |
Founder | 1 |
Sektoral
Consumer Services | 5 |
Health Technology | 2 |
Government | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Edunn Biotechnology, Inc.
Edunn Biotechnology, Inc. Pharmaceuticals: GenericHealth Technology Edunn Biotechnology, Inc. develops drugs to treat central nervous system diseases. The firm engages in developing oligonucleotide drugs to treat central nervous system diseases. The company was founded in September 2005 and is headquartered in St. Louis, MO. | Health Technology |
VA Medical Center (District of Columbia) | Government |
- Börse
- Insiders
- John Edward Morley
- Erfahrung